CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $3.04B, above the global median of $520.53M
- PositionReturn on assets is 6.3%, higher than 95% of its Pharmaceutical Retailers peers (median 1.9%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
7.61%
Annual Rate
BRL 0.26Paid annual
Payout Ratio
51.2%Sustainable
Payback Period
13.1 yr
Last Ex-Dividend
Dec 26, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.42BBRL471.02M · vs all stocks (USD)
Trailing P/E
6.74xvs Pharmaceutical Retailers peers
Revenue (TTM)
15.64BBRL3.04B · vs all stocks (USD)
Profit Margin
2.10%vs Pharmaceutical Retailers peers
Beta
0.0160xvs all stocks
52-Week Change
-8.92%vs all stocks
Market Capitalization
2.42BBRL471.02M · vs all stocks (USD)
Enterprise Value
5.70BBRL1.11B · vs all stocks (USD)
Trailing P/E
6.74xvs Pharmaceutical Retailers peers
Forward P/E
4.94xvs Pharmaceutical Retailers peers
PEG Ratio
0.5768xPrice to Sales (TTM)
0.1549xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
0.7101xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.3650xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
6.07xvs Pharmaceutical Retailers peers
Profit Margin
2.10%vs Pharmaceutical Retailers peers
Operating Margin
6.76%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
6.26%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
10.59%vs Pharmaceutical Retailers peers
Revenue (TTM)
15.64BBRL3.04B · vs all stocks (USD)
Revenue per Share (TTM)
23.35BRLUpdated Aug 22, 2026Quarterly Revenue Growth
8.00%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
5.05BBRL981.94M · vs all stocks (USD)
EBITDA (TTM)
1.23BBRL239.22M · vs all stocks (USD)
Net Income (TTM)
328.41MBRL63.85M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
41.60%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
342.16MBRL66.53M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-80.00MBRL-15.55M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2565BRLUpdated Aug 22, 2026Trailing Annual Dividend Yield
7.61%vs all stocks
Payout Ratio
51.16%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
8.21MBRLFY2025 · Dec 31, 2025Revenue
14.91BBRLFY2025 · Dec 31, 2025Cost of Goods Sold
10.14BBRLFY2025 · Dec 31, 2025Gross Profit
4.76BBRLFY2025 · Dec 31, 2025Operating Income
853.83MBRL166.01M · vs all stocks (USD)
Pre-tax Income
174.97MBRLFY2025 · Dec 31, 2025Income Tax Expense
-85.96MBRLFY2025 · Dec 31, 2025Net Income
260.93MBRLFY2025 · Dec 31, 2025EBIT
679.18MBRLFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.23BBRLFY2025 · Dec 31, 2025Selling, General & Administrative
3.91BBRLFY2025 · Dec 31, 2025Other Operating Expenses
3.22MBRLFY2025 · Dec 31, 2025Non-operating Interest Income
62.61MBRLFY2025 · Dec 31, 2025Non-operating Interest Expense
504.21MBRLFY2025 · Dec 31, 2025Net Income from Continuing Operations
260.93MBRLFY2025 · Dec 31, 2025Minority Interests (P&L)
-648.00KBRLFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025Operating Cash Flow
-296.61MBRLFY2025 · Dec 31, 2025Free Cash Flow
-510.91MBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
185.76MBRLFY2025 · Dec 31, 2025Starting Profit (CF Statement)
260.93MBRLFY2025 · Dec 31, 2025Other Non-cash Items
448.00MBRLFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-617.49MBRLFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-388.05MBRLFY2025 · Dec 31, 2025Capital Expenditures
-214.30MBRLFY2025 · Dec 31, 2025Net Intangibles (CF)
-47.13MBRLFY2025 · Dec 31, 2025Sale of Investments
195.00KBRLFY2025 · Dec 31, 2025Net Investing Cash Flow
-214.10MBRLFY2025 · Dec 31, 2025Long-term Debt Issuance
1.27BBRLFY2025 · Dec 31, 2025Long-term Debt Payments
-931.63MBRLFY2025 · Dec 31, 2025Common Stock Repurchase
-16.49MBRLFY2025 · Dec 31, 2025Common Dividends Paid
-176.41MBRLFY2025 · Dec 31, 2025Net Financing Cash Flow
406.75MBRLFY2025 · Dec 31, 2025Shares Outstanding
718.86MSharesUpdated Aug 22, 2026Float Shares
175.94MSharesUpdated Aug 22, 2026% Held by Insiders
56.10%vs all stocks
% Held by Institutions
31.48%vs all stocks
Total Cash (MRQ)
111.18MBRL21.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1540BRLUpdated Aug 22, 2026Total Debt (MRQ)
3.49BBRL678.01M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.02xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.78xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
4.75BRLUpdated Aug 22, 2026Total Assets
9.92BBRL1.93B · vs all stocks (USD)
Total Current Assets
5.69BBRLFY2025 · Dec 31, 2025Total Liabilities
6.83BBRLFY2025 · Dec 31, 2025Total Non-current Assets
4.23BBRLFY2025 · Dec 31, 2025Total Non-current Liabilities
3.25BBRLFY2025 · Dec 31, 2025Total Current Liabilities
3.58BBRLFY2025 · Dec 31, 2025Cash
53.84MBRLFY2025 · Dec 31, 2025Cash Equivalents
131.92MBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents
185.76MBRLFY2025 · Dec 31, 2025Other Short-term Investments
37.00KBRLFY2025 · Dec 31, 2025Accounts Receivable
1.23BBRLFY2025 · Dec 31, 2025Inventory
3.70BBRLFY2025 · Dec 31, 2025Accounts Payable
2.61BBRLFY2025 · Dec 31, 2025Short-term Debt
478.06MBRLFY2025 · Dec 31, 2025Long-term Debt
3.21BBRLFY2025 · Dec 31, 2025Other Non-current Liabilities
12.98MBRLFY2025 · Dec 31, 2025Common Stock (Book)
1.97BBRLFY2025 · Dec 31, 2025Retained Earnings
0.00BRLFY2025 · Dec 31, 2025Total Shareholders' Equity
3.09BBRL601.45M · vs all stocks (USD)
52-Week Low
3.09BRLUpdated Aug 22, 202652-Week High
7.62BRLUpdated Aug 22, 202652-Week Change
-8.92%vs all stocks
Beta
0.0160xvs all stocks
50-Day MA
3.52BRLUpdated Aug 22, 2026200-Day MA
5.24BRLUpdated Aug 22, 2026Avg 10-Day Volume
3.65MSharesUpdated Aug 22, 2026Avg 30-Day Volume
4.77MSharesUpdated Aug 22, 2026Diluted EPS (TTM)
0.5000BRLUpdated Aug 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
High Current Ratio With Elevated Payables and Inventory Shares
Current assets cover its bills, though much of that is inventory and much is owed out.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on assets is 6.3%, higher than 95% of its Pharmaceutical Retailers peers (median 1.9%)Significant
Return on assets: 0.06Industry median: 0.02Industry P95: 0.06Peers compared: 22.00
P/E ratio is 6.74×, lower than 95% of its Pharmaceutical Retailers peers (median 21.34×)Notable
P/E ratio: 6.74Industry median: 21.34Industry P5: 11.85Peers compared: 22.00
Price-to-book is 0.71×, lower than 95% of its Pharmaceutical Retailers peers (median 1.84×)Notable
Price-to-book: 0.71Industry median: 1.84Industry P5: 0.75Peers compared: 22.00
Financial Health
Altman Z-Score 2.2: grey zoneSignificant
Altman Z-Score: 2.20
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $3.04B, above the global median of $520.53MNotable
Revenue (USD): 3,040,394,128.927Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Mammy Mart Corporation
Tier 1FlowUnit ReplicationInterfaceProduction
Guan Chao Holdings Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
Lindex Group Oyj
Tier 1FlowUnit ReplicationRiskInterface
Mears Group plc
Tier 1FlowUnit ReplicationRuleProduction
Taiwan Shin Kong Security Co., Ltd.
Tier 1FlowUnit ReplicationRuleProduction
Delek Automotive Systems Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
Inner Mongolia Xinhua Distribution Group Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceAttention
Padini Holdings Berhad
Tier 1FlowUnit ReplicationRiskInterface
Barnes & Noble Education Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Jm Holdings Co. Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Xianheng International Science And Technology Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
GSP Automotive Group Wenzhou Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Shanghai Yanpu Metal Products Co. Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth